Matches in Nanopublications for { ?s ?p "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 20 of
20
with 100 items per page.
- NP867307.RAC4fX-AY_JTgXPnuwYpX4TUuNnvyeVAlPQCZ8CcIE5e8130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867307.RAC4fX-AY_JTgXPnuwYpX4TUuNnvyeVAlPQCZ8CcIE5e8130_provenance.
- NP937186.RAaApOnYvNQJMuN8XjqADgqCN6d4wdcnr9o_7FltfbIxQ130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937186.RAaApOnYvNQJMuN8XjqADgqCN6d4wdcnr9o_7FltfbIxQ130_provenance.
- NP247164.RAJzauiNPjH8TZxGlQlPNRp4EfIS3X550fOihzBtKZNHU130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247164.RAJzauiNPjH8TZxGlQlPNRp4EfIS3X550fOihzBtKZNHU130_provenance.
- NP246128.RAu9chzZQF4qCHkDVBTwEhcpRUy3zllqcsXajZ4CkFpcw130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246128.RAu9chzZQF4qCHkDVBTwEhcpRUy3zllqcsXajZ4CkFpcw130_provenance.
- NP348094.RAkH7-oyi8M_pJQUk9MBwWy2hZK5S5yLOJDXh-IkuZMug130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348094.RAkH7-oyi8M_pJQUk9MBwWy2hZK5S5yLOJDXh-IkuZMug130_provenance.
- NP484712.RAA-RRAElC325GnYBQFzQUXg3K4nEziesY4AgsVgdNkic130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484712.RAA-RRAElC325GnYBQFzQUXg3K4nEziesY4AgsVgdNkic130_provenance.
- NP388124.RAjnWblsV3ZTPlyMCvF3M97PfAycQVNpEvzL6WSUITcdQ130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388124.RAjnWblsV3ZTPlyMCvF3M97PfAycQVNpEvzL6WSUITcdQ130_provenance.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_provenance.
- NP699421.RAsAezrYWBeh446m0CNzPGhgjKnysLzZO1RfKF9XvFvhk130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699421.RAsAezrYWBeh446m0CNzPGhgjKnysLzZO1RfKF9XvFvhk130_provenance.
- NP580042.RA-mGw1D7N2dM_NxVuRzmw-Sqx023jVGssHC9bCRFS3Wg130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580042.RA-mGw1D7N2dM_NxVuRzmw-Sqx023jVGssHC9bCRFS3Wg130_provenance.
- NP807638.RA5nlE3gGaH7TUwbMLJ7fHuaw1l6SvrU1YfxCRavCIJbs130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807638.RA5nlE3gGaH7TUwbMLJ7fHuaw1l6SvrU1YfxCRavCIJbs130_provenance.
- NP639662.RA5HA6uqj5YH2zSy-Fr1jxHIXxSX_et25Kv9CoZmPw78k130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639662.RA5HA6uqj5YH2zSy-Fr1jxHIXxSX_et25Kv9CoZmPw78k130_provenance.
- NP523467.RAH_Cb7jnzwinZaH6iR2VGczVMo-hx-q2_tgFZvzwpR-Q130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523467.RAH_Cb7jnzwinZaH6iR2VGczVMo-hx-q2_tgFZvzwpR-Q130_provenance.
- assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP339145.RAAZh7bRTQ8-EDUFZE8lOHDR0VL_bIptQNjsB9XC3HDJo130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339145.RAAZh7bRTQ8-EDUFZE8lOHDR0VL_bIptQNjsB9XC3HDJo130_provenance.
- NP859580.RAMcwsj6SrdDRgZfXGpcANl6Xb9uO5HLGu8-AttPN4WQw130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859580.RAMcwsj6SrdDRgZfXGpcANl6Xb9uO5HLGu8-AttPN4WQw130_provenance.
- assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP339144.RAq2RQcoCKbU1cWfEmQqGZQvqoBRmbp5hllfum4yyKSjw130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339144.RAq2RQcoCKbU1cWfEmQqGZQvqoBRmbp5hllfum4yyKSjw130_provenance.
- NP928831.RAy-wWULpzWFtWdBhu-FdurvbOzWGJOhclgejh_mwgJOM130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928831.RAy-wWULpzWFtWdBhu-FdurvbOzWGJOhclgejh_mwgJOM130_provenance.
- NP339141.RAwv8ZaOKTImf6zpIzmtWibyqI46PRPrCKepwl7F85PTA130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339141.RAwv8ZaOKTImf6zpIzmtWibyqI46PRPrCKepwl7F85PTA130_provenance.